Contact: Science Press Package
American Association for the Advancement of Science
Caption: A single intravenous infusion of the dual-drug vehicle resulted in remarkable tumor reduction in both non-small cell lung cancer and triple negative breast cancer, whereas single drug and untreated controls show significant tumor growth in both cancer cell types over this period. This image relates to a paper that appeared in May 13, 2014, issue of Science Signaling, published by AAAS. The paper, by Stephen W. Morton at Massachusetts Institute of Technology in Cambridge, Mass., and colleagues was titled, "A Nanoparticle-Based Combination Chemotherapy Delivery System for Enhanced Tumor Killing by Dynamic Rewiring of Signaling Pathways."
Credit: [Credit: Stephen Morton]
Usage Restrictions: Please cite the owner of the image when publishing. This image may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact Science for permission.